Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells

MLA

Sangmin Kim, et al. “Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells.” Biomedicines, vol. 11, Feb. 2023, p. 675. EBSCOhost, https://doi.org/10.3390/biomedicines11030675.

APA

Sangmin Kim, Hyungjoo Kim, Yisun Jeong, Daeun You, Sun Young Yoon, Eunji Lo, Seok Jin Nam, Jeong Eon Lee, & Seok Won Kim. (2023). Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells. Biomedicines, 11, 675. https://doi.org/10.3390/biomedicines11030675

Chicago

Sangmin Kim, Hyungjoo Kim, Yisun Jeong, Daeun You, Sun Young Yoon, Eunji Lo, Seok Jin Nam, Jeong Eon Lee, and Seok Won Kim. 2023. “Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells.” Biomedicines 11 (February): 675. doi:10.3390/biomedicines11030675.